24 March 2020

Fight against COVID-19 fraud is new investigation priority of the US Department of Justice

The US Department of Justice (DOJ) has directed all US Attorneys to actively detect, deter and punish misconduct related to the COVID-19 Pandemic.

We live in challenging times. As if keeping the spreading Corona virus at bay were the only threat, more and more crisis profiteers are apparently trying their luck – essentially highlighting the necessity of a vigilant and responsive legal system. Please read our GSK Compliance update.

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 30.03.2020

    GSK Update: Impact of the coronavirus pandemic on contractual relationships

    Read more
  • 26.03.2020

    GSK Update: Impact of COVID-19 on Luxembourg investment funds: regulatory measures

    Read more
  • 25.03.2020

    GSK Update: German lawmakers suspend obligation to file for insolvency

    Read more
Contact person

Eric Mayer

Local Partner*

+49 89 288174-73

eric.mayer@gsk.de